01993D0152 — EN — 01.12.2010 — 001.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION DECISION

of 8 February 1993

laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes

(93/152/EEC)

(OJ L 059 12.3.1993, p. 35)

Amended by:

 

 

Official Journal

  No

page

date

►M1

COMMISSION DECISION  of 22 October 2010

  L 279

33

23.10.2010




▼B

COMMISSION DECISION

of 8 February 1993

laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes

(93/152/EEC)



Article 1

For the use in routine vaccination programmes:

(a) 

live attenuated Newcastle disease vaccines shall be prepared from a Newcastle disease virus strain for which the master seed has been tested and shown to have an intracerebral pathogenicity index (ICPI) of:

(i) 

less than 0,4 if not less than 107 EID50 are administrated to each bird in the ICPI test;

or

(ii) 

less than 0,5 if not less than 108 EID50 are administered to each bird, in the ICPI test;

▼M1 —————

▼B

Article 2

The present Decision shall apply from 1 January 1995.

Article 3

This Decision is addressed to the Member States.



( 1 )  OJ No L 303, 31.10.1990, p. 6.

( 2 )  OJ No L 268, 14.9.1992, p. 54.